The clinical data showed that the expression of METTL3 (Fig. 8C) and ZEB2 (Fig. 8D) in RFs was significantly greater than that in adjacent normal tissues from renal cell carcinoma patients. The gene discussed is METTL3; the disease is renal cell carcinoma.